Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials.

Ronellenfitsch U, Jensen K, Seide S, Kieser M, Schwarzbach M, Slanger TE, Burmeister B, Kelsen D, Niedzwiecki D, Piessen G, Schuhmacher C, Urba S, van de Velde C, Ychou M, Hofheinz R, Lorenzen S.

Eur J Cancer. 2019 Dec;123:101-111. doi: 10.1016/j.ejca.2019.10.001. Epub 2019 Nov 1.

PMID:
31678767
2.

Laboratory Studies of Vibrational Excitation in O2( a1Δg, v) Involving O2, N2, and CO2.

Slanger TG, Hwang ES, Bartlett NC, Kalogerakis KS.

J Phys Chem A. 2018 Oct 18;122(41):8114-8125. doi: 10.1021/acs.jpca.8b07469. Epub 2018 Oct 9.

PMID:
30299092
3.

Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).

Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Nowak K, Kieser M, Slanger TE, Burmeister B, Kelsen D, Niedzwiecki D, Schuhmacher C, Urba S, van de Velde C, Walsh TN, Ychou M, Jensen K.

Eur J Surg Oncol. 2017 Aug;43(8):1550-1558. doi: 10.1016/j.ejso.2017.05.005. Epub 2017 May 18.

PMID:
28551325
4.

Person-directed, non-pharmacological interventions for sleepiness at work and sleep disturbances caused by shift work.

Slanger TE, Gross JV, Pinger A, Morfeld P, Bellinger M, Duhme AL, Reichardt Ortega RA, Costa G, Driscoll TR, Foster RG, Fritschi L, Sallinen M, Liira J, Erren TC.

Cochrane Database Syst Rev. 2016 Aug 23;(8):CD010641. doi: 10.1002/14651858.CD010641.pub2. Review.

PMID:
27549931
5.

Comment on "Diversity Outbred: A New Generation of Mouse Model".

Erren TC, Slanger TE, Groß JV, Reiter RJ.

Environ Health Perspect. 2015 Sep;123(9):A232. doi: 10.1289/ehp.1510098. No abstract available.

6.

Stopping possible sexual transmission of filoviruses.

Gross JV, Slanger TE, Cullen P, Erren M, Erren TC.

Clin Infect Dis. 2015 Jun 15;60(12):1871-2. doi: 10.1093/cid/civ188. Epub 2015 Mar 12. No abstract available.

PMID:
25767255
7.

Ten simple rules for lifelong learning, according to Hamming.

Erren TC, Slanger TE, Groß JV, Bourne PE, Cullen P.

PLoS Comput Biol. 2015 Feb 26;11(2):e1004020. doi: 10.1371/journal.pcbi.1004020. eCollection 2015 Feb. No abstract available.

8.

Melatonin, sleep, and prostate cancer in elderly men: study, hypothesis development, and icelandic options.

Erren TC, Slanger TE, Groß JV, Reiter RJ.

Eur Urol. 2015 Feb;67(2):195-7. doi: 10.1016/j.eururo.2014.09.033. Epub 2014 Oct 1. No abstract available.

PMID:
25282366
9.

O2(b(1)Σ(+)(g), υ = 0, 1) relative yields in O((1)D) + O2 energy transfer.

Pejaković DA, Copeland RA, Slanger TG, Kalogerakis KS.

J Chem Phys. 2014 Jul 14;141(2):024303. doi: 10.1063/1.4885721.

PMID:
25028015
10.

Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.

Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Kieser M, Slanger TE, Burmeister B, Kelsen D, Niedzwiecki D, Schuhmacher C, Urba S, van de Velde C, Walsh TN, Ychou M, Jensen K.

Eur J Cancer. 2013 Oct;49(15):3149-58. doi: 10.1016/j.ejca.2013.05.029. Epub 2013 Jun 22. Review.

PMID:
23800671
11.

Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.

Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Kieser M, Slanger TE, Jensen K; GE Adenocarcinoma Meta‐analysis Group.

Cochrane Database Syst Rev. 2013 May 31;(5):CD008107. doi: 10.1002/14651858.CD008107.pub2. Review.

PMID:
23728671
12.

Collisional relaxation of O2(X3Σg(-), υ = 1) and O2(a1Δg, υ = 1) by atmospherically relevant species.

Pejaković DA, Campbell Z, Kalogerakis KS, Copeland RA, Slanger TG.

J Chem Phys. 2011 Sep 7;135(9):094309. doi: 10.1063/1.3624378.

PMID:
21913765
13.

Chemical origins of the Mars ultraviolet dayglow.

Huestis DL, Slanger TG, Sharpee BD, Fox JL.

Faraday Discuss. 2010;147:307-22; discussion 379-403.

PMID:
21302553
14.

Physical activity and postmenopausal breast cancer: effect modification by other breast cancer risk factors.

Schmidt ME, Chang-Claude J, Slanger T, Obi N, Flesch-Janys D, Steindorf K.

Methods Inf Med. 2009;48(5):444-50. doi: 10.3414/ME9239. Epub 2009 Aug 20.

PMID:
19696953
15.

The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a German case-control study.

Obi N, Chang-Claude J, Berger J, Braendle W, Slanger T, Schmidt M, Steindorf K, Ahrens W, Flesch-Janys D.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2207-13. doi: 10.1158/1055-9965.EPI-09-0298. Erratum in: Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2567.

16.

Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.

Barnes BB, Chang-Claude J, Flesch-Janys D, Kinscherf R, Schmidt M, Slanger T, Bonaterra G, Steindorf K.

Cancer Causes Control. 2009 Dec;20(10):1985-96. doi: 10.1007/s10552-009-9393-0.

PMID:
19597750
17.

Menopausal hormone therapy and risk of clinical breast cancer subtypes.

Slanger TE, Chang-Claude JC, Obi N, Kropp S, Berger J, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Flesch-Janys D.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1188-96. doi: 10.1158/1055-9965.EPI-09-0002. Epub 2009 Mar 31.

18.

Physical activity and postmenopausal breast cancer: effect modification by breast cancer subtypes and effective periods in life.

Schmidt ME, Steindorf K, Mutschelknauss E, Slanger T, Kropp S, Obi N, Flesch-Janys D, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3402-10. doi: 10.1158/1055-9965.EPI-08-0479. Epub 2008 Nov 24.

19.

The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1339-43. doi: 10.1158/1055-9965.EPI-08-0162.

20.

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy.

Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Berger J, Chang-Claude J.

Int J Cancer. 2008 Aug 15;123(4):933-41. doi: 10.1002/ijc.23655.

21.

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.

Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, Bojesen SE, Nordestgaard BG, Axelsson CK, Arias JI, Milne RL, Ribas G, González-Neira A, Benítez J, Zamora P, Brauch H, Justenhoven C, Hamann U, Ko YD, Bruening T, Haas S, Dörk T, Schürmann P, Hillemanns P, Bogdanova N, Bremer M, Karstens JH, Fagerholm R, Aaltonen K, Aittomäki K, von Smitten K, Blomqvist C, Mannermaa A, Uusitupa M, Eskelinen M, Tengström M, Kosma VM, Kataja V, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X; Australian Ovarian Cancer Management Group; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Devilee P, van Asperen CJ, Jacobi CE, Tollenaar RA, Huijts PE, Klijn JG, Chang-Claude J, Kropp S, Slanger T, Flesch-Janys D, Mutschelknauss E, Salazar R, Wang-Gohrke S, Couch F, Goode EL, Olson JE, Vachon C, Fredericksen ZS, Giles GG, Baglietto L, Severi G, Hopper JL, English DR, Southey MC, Haiman CA, Henderson BE, Kolonel LN, Le Marchand L, Stram DO, Hunter DJ, Hankinson SE, Cox DG, Tamimi R, Kraft P, Sherman ME, Chanock SJ, Lissowska J, Brinton LA, Peplonska B, Klijn JG, Hooning MJ, Meijers-Heijboer H, Collee JM, van den Ouweland A, Uitterlinden AG, Liu J, Lin LY, Yuqing L, Humphreys K, Czene K, Cox A, Balasubramanian SP, Cross SS, Reed MW, Blows F, Driver K, Dunning A, Tyrer J, Ponder BA, Sangrajrang S, Brennan P, McKay J, Odefrey F, Gabrieau V, Sigurdson A, Doody M, Struewing JP, Alexander B, Easton DF, Pharoah PD.

PLoS Genet. 2008 Apr 25;4(4):e1000054. doi: 10.1371/journal.pgen.1000054.

22.

Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.

Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Breast Cancer Res. 2008;10(2):R31. doi: 10.1186/bcr1994. Epub 2008 Apr 17.

23.

Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis.

Frank B, Wiestler M, Kropp S, Hemminki K, Spurdle AB, Sutter C, Wappenschmidt B, Chen X, Beesley J, Hopper JL; Australian Breast Cancer Family Study Investigators,, Meindl A, Kiechle M, Slanger T, Bugert P, Schmutzler RK, Bartram CR, Flesch-Janys D, Mutschelknauss E, Ashton K, Salazar R, Webb E, Hamann U, Brauch H, Justenhoven C, Ko YD, Brüning T, Silva Idos S, Johnson N, Pharoah PP, Dunning AM, Pooley KA, Chang-Claude J, Easton DF, Peto J, Houlston R; Gene Environment Interaction and Breast Cancer in Germany Group, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer Investigators, Australian Ovarian Cancer Study Management Group, Chenevix-Trench G, Fletcher O, Burwinkel B.

J Natl Cancer Inst. 2008 Mar 19;100(6):437-42. doi: 10.1093/jnci/djn037. Epub 2008 Mar 11.

PMID:
18334708
24.

Good agreement between physician and self-reported hormone therapy data in a case-control study.

Kropp S, Terboven T, Hedicke J, Mutschelknauss E, Slanger T, Braendle W, Berger J, Chang-Claude J, Flesch-Janys D.

J Clin Epidemiol. 2007 Dec;60(12):1280-7. Epub 2007 Jun 28.

PMID:
17998083
25.

Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Carcinogenesis. 2008 Jan;29(1):93-9. Epub 2007 Oct 31.

PMID:
17974532
26.

Test-retest reliability of self-reported reproductive and lifestyle data in the context of a German case-control study on breast cancer and postmenopausal hormone therapy.

Slanger T, Mutschelknauss E, Kropp S, Braendle W, Flesch-Janys D, Chang-Claude J.

Ann Epidemiol. 2007 Dec;17(12):993-8. Epub 2007 Sep 14.

PMID:
17855123
27.

Evaluation of a short retrospective questionnaire for physical activity in women.

Schmidt ME, Slanger T, Chang-Claude J, Wahrendorf J, Steindorf K.

Eur J Epidemiol. 2006;21(8):575-85. Epub 2006 Sep 27.

PMID:
17004027
28.

Manganese superoxide dismutase Ala-9Val polymorphism, environmental modifiers, and risk of breast cancer in a German population.

Slanger TE, Chang-Claude J, Wang-Gohrke S.

Cancer Causes Control. 2006 Oct;17(8):1025-31.

PMID:
16933053
29.
30.

Measurement of the rate coefficient for collisional removal of O2(X3Sigma- g, upsilon=1) by O(3P).

Kalogerakis KS, Copeland RA, Slanger TG.

J Chem Phys. 2005 Nov 15;123(19):194303.

PMID:
16321084
31.

Vibrational energy transfer in O2(X 3sigma(g)-, upsilon=2,3) + O2 collisions at 330 K.

Kalogerakis KS, Copeland RA, Slanger TG.

J Chem Phys. 2005 Jul 22;123(4):044309.

PMID:
16095360
32.
33.

Energetic oxygen in the upper atmosphere and the laboratory.

Slanger TG, Copeland RA.

Chem Rev. 2003 Dec;103(12):4731-66. No abstract available.

PMID:
14664631
34.

The association between female genital cutting and correlates of sexual and gynaecological morbidity in Edo State, Nigeria.

Okonofu FE, Larsen U, Oronsaye F, Snow RC, Slanger TE.

BJOG. 2002 Oct;109(10):1089-96.

35.

The practice of STI treatment among chemists and druggists in Pokhara, Nepal.

Bista KP, Chaudhary P, Slanger TE, Khan MH.

Sex Transm Infect. 2002 Jun;78(3):223. No abstract available.

36.

The impact of female genital cutting on first delivery in southwest Nigeria.

Slanger TE, Snow RC, Okonofua FE.

Stud Fam Plann. 2002 Jun;33(2):173-84.

PMID:
12132637
37.

Female genital cutting in southern urban and peri-urban Nigeria: self-reported validity, social determinants and secular decline.

Snow RC, Slanger TE, Okonofua FE, Oronsaye F, Wacker J.

Trop Med Int Health. 2002 Jan;7(1):91-100.

38.

Discovery of the atomic oxygen green line in the Venus night airglow.

Slanger TG, Cosby PC, Huestis DL, Bida TA.

Science. 2001 Jan 19;291(5503):463-5.

39.

Energetic molecular oxygen in the atmosphere.

Slanger TG.

Science. 1994 Sep 23;265(5180):1817-8. No abstract available.

PMID:
17797217
40.

The spectrum of comet austin.

Slanger TG.

Science. 1991 Jul 26;253(5018):452. No abstract available.

PMID:
17746402
41.

In reply: formation of ozone by irradiation of oxygen at 248 nanometers.

Slanger TG, Gadd GE.

Science. 1990 Dec 7;250(4986):1433-4. No abstract available.

PMID:
17754988
42.

A new laboratory source of ozone and its potential atmospheric implications.

Slanger TG, Jusinski LE, Black G, Gadd GE.

Science. 1988 Aug 19;241(4868):945-50.

PMID:
17731442
43.

Metastable oxygen emission bands.

Slanger TG.

Science. 1978 Nov 17;202(4369):751-3.

PMID:
17807249

Supplemental Content

Loading ...
Support Center